300294 博雅生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)4.5255.3623.2746.1686.300
总资产报酬率 ROA (%)4.0054.8922.9945.5225.392
投入资产回报率 ROIC (%)4.3135.2043.2336.0816.013

边际利润分析
销售毛利率 (%)54.20464.65452.75854.65756.982
营业利润率 (%)23.22727.50913.39519.29116.716
息税前利润/营业总收入 (%)22.31526.06112.18818.36815.941
净利润/营业总收入 (%)23.27422.8569.35716.14813.517

收益指标分析
经营活动净收益/利润总额(%)72.02095.379159.564100.786108.372
价值变动净收益/利润总额(%)21.45616.46328.2018.2409.729
营业外收支净额/利润总额(%)-0.2960.096-0.428-0.0340.014

偿债能力分析
流动比率 (X)5.5686.74114.0828.6118.948
速动比率 (X)4.3505.41512.8627.6657.876
资产负债率 (%)12.08510.8726.4909.3169.201
带息债务/全部投入资本 (%)3.0902.5180.8300.7080.819
股东权益/带息债务 (%)3,081.9203,788.90111,905.02713,936.38612,032.500
股东权益/负债合计 (%)727.319819.7171,440.684960.198973.774
利息保障倍数 (X)-26.453-17.680-10.600-20.046-20.505

营运能力分析
应收账款周转天数 (天)100.47868.30145.58059.16560.914
存货周转天数 (天)422.937455.674175.840193.372215.694